U.S. Health Agencies Will Decide if COVID-19 Booster Shots Are Needed – – Not Vaccine Companies + More
, the stage 2/3 study of the vaccine in teenagers met its main immunogenicity endpoint. It showed to have 93% effectiveness 14 days after the very first dose.
, the stage 2/3 study of the vaccine in adolescents met its primary immunogenicity endpoint. It proved to have 93% efficacy 14 days after the very first dosage.
